• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病中肺动脉高压的演变

Evolution of pulmonary hypertension in chronic obstructive pulmonary diseases.

作者信息

Weitzenblum E, Mammosser M, Ehrhart M

出版信息

G Ital Cardiol. 1984;14 Suppl 1:33-8.

PMID:6534764
Abstract

The prognostic value of the presence and degree of pulmonary arterial hypertension in chronic obstructive pulmonary diseases has been well established, but the natural history of the course of pulmonary artery mean pressure was relatively obscure until recent years. The first studies showed a modest increase in pulmonary artery mean pressure after an average delay of 3-5 years. More recently, studying a group of 35 patients with chronic bronchitis, most of them exhibiting pulmonary arterial hypertension followed-up for a mean period of 3 years, Schrijen et al. did not observe a significant change in pulmonary artery mean pressure in patients with or without initial pulmonary arterial hypertension; a marked decrease in systemic arterial pressure occurred in one third of the patients. In 1979 studying a series of 85 chronic obstructive pulmonary diseases patients, we noticed that pulmonary artery mean pressure slightly increased in patients with or without initial pulmonary arterial hypertension, but the average increase, after five years, for the group taken as a whole was only 0.6 mmHg/year. When putting together the data of Boushy and North, Schrijen et al. and Weitzenblum et al. which concern a relatively homogeneous group of 163 patients with severe chronic obstructive pulmonary diseases, it appears that changes in pulmonary artery mean pressure, after an average follow-up period of 4 years, were rather small, from 21.4 to 23.6 mmHg (0.5-0.6 mmHg/year). These results have been confirmed by a very recent study of our group concerning 93 chronic obstructive pulmonary diseases with patients followed-up for 5-12 years (mean = 90 months).

摘要

肺动脉高压的存在及程度在慢性阻塞性肺疾病中的预后价值已得到充分证实,但直到近年来,肺动脉平均压的病程自然史仍相对模糊。最初的研究表明,平均延迟3 - 5年后,肺动脉平均压有适度升高。最近,施里扬等人对一组35例慢性支气管炎患者进行了研究,其中大多数患者患有肺动脉高压,平均随访3年,他们未观察到有或无初始肺动脉高压患者的肺动脉平均压有显著变化;三分之一的患者出现了显著的体循环动脉压下降。1979年,我们对一系列85例慢性阻塞性肺疾病患者进行研究时注意到,有或无初始肺动脉高压患者的肺动脉平均压均略有升高,但作为一个整体的组在5年后的平均升高仅为每年0.6 mmHg。当汇总布希、诺思、施里扬等人以及魏岑布卢姆等人关于163例重度慢性阻塞性肺疾病相对同质组的数据时,似乎在平均随访4年后,肺动脉平均压的变化相当小,从21.4 mmHg升至23.6 mmHg(每年0.5 - 0.6 mmHg)。我们小组最近对93例慢性阻塞性肺疾病患者进行的一项研究,随访时间为5 - 12年(平均 = 90个月),证实了这些结果。

相似文献

1
Evolution of pulmonary hypertension in chronic obstructive pulmonary diseases.慢性阻塞性肺疾病中肺动脉高压的演变
G Ital Cardiol. 1984;14 Suppl 1:33-8.
2
Evolution and prognosis of pulmonary hypertension in chronic obstructive pulmonary diseases.
Herz. 1986 Jun;11(3):147-54.
3
[Course study of pulmonary artery pressure in patients with chronic obstructive bronchitis].[慢性阻塞性支气管炎患者肺动脉压的病程研究]
Z Erkr Atmungsorgane. 1985;164(1):67-73.
4
Prognosis of pulmonary hypertension in chronic obstructive pulmonary disease.
Cor Vasa. 1980;22(6):418-27.
5
[The prognostic significance of pulmonary arterial hypertension in chronic obstructive airway disease (author's transl)].慢性阻塞性气道疾病中肺动脉高压的预后意义(作者译)
Poumon Coeur. 1981;37(3):177-84.
6
[Development of pulmonary arterial hypertension in chronic obstructive bronchopneumopathies].
Schweiz Med Wochenschr. 1989 Oct 28;119(43):1506-10.
7
Evaluation problems of a long-term study on evolving pulmonary arterial hypertension in chronic non specific lung disease.慢性非特异性肺病中肺动脉高压演变的长期研究的评估问题
G Ital Cardiol. 1984;14 Suppl 1:49-55.
8
[Follow-up in patients with chronic obstructive lung diseases with special reference to the pressure behavior in the pulmonary artery].[慢性阻塞性肺疾病患者的随访,特别关注肺动脉压力变化]
Z Erkr Atmungsorgane. 1987;169(2):109-16.
9
Effects of oxygen therapy on pulmonary arterial hypertension in chronic obstructive lung disease.
G Ital Cardiol. 1984;14 Suppl 1:61-3.
10
Effects of theophylline-ethylendiamine on chronic pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.
G Ital Cardiol. 1984;14 Suppl 1:74-6.

引用本文的文献

1
[Right ventricular function and pulmonary hypertension].
Med Klin (Munich). 1997 Jan 15;92(1):18-24. doi: 10.1007/BF03042277.